74
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Microscopic Colitis and Risk of Incident Psoriasis: A Nationwide Population-Based Matched Cohort Study

, , ORCID Icon, , , , & ORCID Icon show all
Pages 213-225 | Received 13 Dec 2023, Accepted 25 Mar 2024, Published online: 29 Mar 2024

References

  • Burke KE, D’Amato M, Ng SC, Pardi DS, Ludvigsson JF, Khalili H. Microscopic colitis. Nat Rev Dis Primers. 2021;7(1):39.
  • Bergman D, Clements MS, Khalili H, Agreus L, Hultcrantz R, Ludvigsson JF. A nationwide cohort study of the incidence of microscopic colitis in Sweden. Aliment Pharmacol Ther. 2019;49(11):1395–1400. doi:10.1111/apt.15246
  • Mellander MR, Ekbom A, Hultcrantz R, Lofberg R, Ost A, Bjork J. Microscopic colitis: a descriptive clinical cohort study of 795 patients with collagenous and lymphocytic colitis. Scand J Gastroenterol. 2016;51(5):556–562. doi:10.3109/00365521.2015.1124283
  • Miehlke S, Verhaegh B, Tontini GE, Madisch A, Langner C, Munch A. Microscopic colitis: pathophysiology and clinical management. Lancet Gastroenterol Hepatol. 2019;4(4):305–314. doi:10.1016/S2468-1253(19)30048-2
  • Langner C, Aust D, Ensari A, et al. Histology of microscopic colitis-review with a practical approach for pathologists. Histopathology. 2015;66(5):613–626. doi:10.1111/his.12592
  • Lebwohl M. Psoriasis. Lancet. 2003;361(9364):1197–1204. doi:10.1016/S0140-6736(03)12954-6
  • Gelfand JM, Gladman DD, Mease PJ, et al. Epidemiology of psoriatic arthritis in the population of the United States. J Am Acad Dermatol. 2005;53(4):573. doi:10.1016/j.jaad.2005.03.046
  • Reich K, Kruger K, Mossner R, Augustin M. Epidemiology and clinical pattern of psoriatic arthritis in Germany: a prospective interdisciplinary epidemiological study of 1511 patients with plaque-type psoriasis. Br J Dermatol. 2009;160(5):1040–1047. doi:10.1111/j.1365-2133.2008.09023.x
  • Mease PJ, Gladman DD, Papp KA, et al. Prevalence of rheumatologist-diagnosed psoriatic arthritis in patients with psoriasis in European/North American dermatology clinics. J Am Acad Dermatol. 2013;69(5):729–735. doi:10.1016/j.jaad.2013.07.023
  • Gladman DD, Antoni C, Mease P, Clegg DO, Nash P. Psoriatic arthritis: epidemiology, clinical features, course, and outcome. Ann Rheum Dis. 2005;64 Suppl 2(Suppl 2):ii14–7.
  • Parisi R, Symmons DP, Griffiths CE, et al.; Identification, Management of P. Global epidemiology of psoriasis: a systematic review of incidence and prevalence. J Invest Dermatol. 2013;133(2):377–385. doi:10.1038/jid.2012.339
  • Ludvigsson JF, Lindelof B, Zingone F, Ciacci C. Psoriasis in a nationwide cohort study of patients with celiac disease. J Invest Dermatol. 2011;131(10):2010–2016. doi:10.1038/jid.2011.162
  • Fu Y, Lee CH, Chi CC. Association of psoriasis with inflammatory bowel disease: a systematic review and meta-analysis. JAMA Dermatol. 2018;154(12):1417–1423. doi:10.1001/jamadermatol.2018.3631
  • Mohammed A, Ghoneim S, Paranji N, Waghray N. Quantifying risk factors for microscopic colitis: a nationwide, retrospective cohort study. Indian J Gastroenterol. 2022;41(2):181–189. doi:10.1007/s12664-021-01199-z
  • Wildt S, Munck LK, Winther-Jensen M, Jess T, Nyboe Andersen N. Autoimmune diseases in microscopic colitis: a Danish nationwide case-control study. Aliment Pharmacol Ther. 2021;54(11–12):1454–1462. doi:10.1111/apt.16614
  • Vashist S, Mahajan VK, Mehta KS, et al. Association of psoriasis with autoimmune disorders: results of a Pilot Study. Indian Dermatol Online J. 2020;11(5):753–759. doi:10.4103/idoj.IDOJ_648_19
  • Westerlind H, Mellander MR, Bresso F, et al. Dense genotyping of immune-related loci identifies HLA variants associated with increased risk of collagenous colitis. Gut. 2017;66(3):421–428. doi:10.1136/gutjnl-2015-309934
  • Winchester R, Minevich G, Steshenko V, et al. HLA associations reveal genetic heterogeneity in psoriatic arthritis and in the psoriasis phenotype. Arthritis Rheum. 2012;64(4):1134–1144. doi:10.1002/art.33415
  • Ludvigsson JF, Otterblad-Olausson P, Pettersson BU, Ekbom A. The Swedish personal identity number: possibilities and pitfalls in healthcare and medical research. Eur j Epidemiol. 2009;24(11):659–667. doi:10.1007/s10654-009-9350-y
  • Wettermark B, Hammar N, Fored CM, et al. The new Swedish prescribed drug register--opportunities for pharmacoepidemiological research and experience from the first six months. Pharmacoepidemiol Drug Saf. 2007;16(7):726–735. doi:10.1002/pds.1294
  • Evelyn Hovenga TB. Systematized Nomenclature of Medicine. Fragmented global standards development organisations; 2022.
  • Ludvigsson JF, Lashkariani M. Cohort profile: ESPRESSO (Epidemiology Strengthened by histoPathology Reports in Sweden). Clin Epidemiol. 2019;11:101–114. doi:10.2147/CLEP.S191914
  • Bergman D, Khalili H, Roelstraete B, Ludvigsson JF. Microscopic colitis and risk of cancer - a population-based cohort study. J Crohns Colitis. 2020. doi:10.1093/ecco-jcc/jjaa156
  • Svensson M, Bergman D, Olen O, et al. Validating microscopic colitis (MC) in Swedish pathology registers. Scand J Gastroenterol. 2019;2019:1–7.
  • Ludvigsson JF, Almqvist C, Bonamy A-KE, et al. Registers of the Swedish total population and their use in medical research. Eur j Epidemiol. 2016;31(2):125–136. doi:10.1007/s10654-016-0117-y
  • Ludvigsson JF, Andersson E, Ekbom A, et al. External review and validation of the Swedish national inpatient register. BMC Public Health. 2011;11:450. doi:10.1186/1471-2458-11-450
  • Ludvigsson JF, Svedberg P, Olen O, Bruze G, Neovius M. The longitudinal integrated database for health insurance and labour market studies (LISA) and its use in medical research. Eur J Epidemiol. 2019;34(4):423–437. doi:10.1007/s10654-019-00511-8
  • Khalili H, Burke KE, Roelstraete B, Sachs MC, Olen O, Ludvigsson JF. Microscopic colitis and risk of inflammatory bowel disease in a Nationwide Cohort Study. Gastroenterology. 2020;158(6):1574–83 e2. doi:10.1053/j.gastro.2019.12.028
  • Bergman D, Khalili H, Lebwohl B, Roelstraete B, Green PHR, Ludvigsson JF. Celiac disease and risk of microscopic colitis: a nationwide population-based matched cohort study. United Eur Gastroenterol J. 2023;11(2):189–201. doi:10.1002/ueg2.12374
  • Yen EF, Pokhrel B, Du H, et al. Current and past cigarette smoking significantly increase risk for microscopic colitis. Inflamm Bowel Dis. 2012;18(10):1835–1841. doi:10.1002/ibd.22838
  • Naldi L. Psoriasis and smoking: links and risks. Psoriasis. 2016;6:65–71. doi:10.2147/PTT.S85189
  • Sjolander A, Greenland S. Ignoring the matching variables in cohort studies - when is it valid and why? Stat Med. 2013;32(27):4696–4708. doi:10.1002/sim.5879
  • Linden A. Conducting sensitivity analysis for unmeasured confounding in observational studies using E-values: the evalue package. Stata J. 2020;20(1):162–175. doi:10.1177/1536867X20909696
  • Ludvigsson JF, Haberg SE, Knudsen GP, et al. Ethical aspects of registry-based research in the Nordic countries. Clin Epidemiol. 2015;7:491–508. doi:10.2147/CLEP.S90589
  • Jaruvongvanich V, Poonsombudlert K, Ungprasert P. Smoking and risk of microscopic colitis: a systematic review and meta-analysis. Inflamm Bowel Dis. 2019;25(4):672–678. doi:10.1093/ibd/izy296
  • Kumawat AK, Strid H, Tysk C, Bohr J, Hörnquist EH. Microscopic colitis patients demonstrate a mixed Th17/Tc17 and Th1/Tc1 mucosal cytokine profile. Mol Immunol. 2013;55(3–4):355–364. doi:10.1016/j.molimm.2013.03.007
  • Coimbra S, Oliveira H, Reis F, et al. Interleukin (IL)-22, IL-17, IL-23, IL-8, vascular endothelial growth factor and tumour necrosis factor-alpha levels in patients with psoriasis before, during and after psoralen-ultraviolet A and narrowband ultraviolet B therapy. Br J Dermatol. 2010;163(6):1282–1290. doi:10.1111/j.1365-2133.2010.09992.x
  • Arican O, Aral M, Sasmaz S, Ciragil P. Serum levels of TNF-alpha, IFN-gamma, IL-6, IL-8, IL-12, IL-17, and IL-18 in patients with active psoriasis and correlation with disease severity. Mediators Inflamm. 2005;2005(5):273–279. doi:10.1155/MI.2005.273
  • Hawkes JE, Yan BY, Chan TC, Krueger JG. Discovery of the IL-23/IL-17 Signaling Pathway and the Treatment of Psoriasis. J Immunol. 2018;201(6):1605–1613. doi:10.4049/jimmunol.1800013
  • Morgan DM, Cao Y, Miller K, et al. Microscopic colitis is characterized by intestinal dysbiosis. Clin Gastroenterol Hepatol. 2020;18(4):984–986. doi:10.1016/j.cgh.2019.06.035
  • Zhang X, Shi L, Sun T, Guo K, Geng S. Dysbiosis of gut microbiota and its correlation with dysregulation of cytokines in psoriasis patients. BMC Microbiol. 2021;21(1):78. doi:10.1186/s12866-021-02125-1
  • Rindom Krogsgaard L, Kristian Munck L, Bytzer P, Wildt S. An altered composition of the microbiome in microscopic colitis is driven towards the composition in healthy controls by treatment with budesonide. Scand J Gastroenterol. 2019;54(4):446–452. doi:10.1080/00365521.2019.1599064
  • Hidalgo-Cantabrana C, Gomez J, Delgado S, et al. Gut microbiota dysbiosis in a cohort of patients with psoriasis. Br J Dermatol. 2019;181(6):1287–1295. doi:10.1111/bjd.17931
  • Buhas MC, Gavrilas LI, Candrea R, et al. Gut Microbiota in Psoriasis. Nutrients. 2022;14(14):2970. doi:10.3390/nu14142970
  • Lofvendahl S, Theander E, Svensson A, Carlsson KS, Englund M, Petersson IF. Validity of diagnostic codes and prevalence of physician-diagnosed psoriasis and psoriatic arthritis in southern Sweden--a population-based register study. PLoS One. 2014;9(5):e98024. doi:10.1371/journal.pone.0098024
  • Liu PH, Burke KE, Ananthakrishnan AN, et al. Obesity and weight gain since early adulthood are associated with a lower risk of microscopic colitis. Clin Gastroenterol Hepatol. 2019;17(12):2523–32.e1. doi:10.1016/j.cgh.2018.11.057